{
  "functional_evidence_assessment": {
    "variant_id": [
      {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      }
    ],
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset Parkinson's disease (PD).",
        "judgment": "Yes",
        "reasoning": "The paper explicitly mentions that mutations in the LRRK2 gene are associated with PD, thus defining the disease mechanism."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "KESTREL screen was used to identify proteins phosphorylated by an activated PD mutant of LRRK2 (G2019S).",
        "judgment": "Yes",
        "reasoning": "The paper describes an experimental approach involving a kinase substrate tracking and elucidation screen, which is applicable for assessing the functionality of LRRK2 mutations."
      },
      {
        "step_name": "Sub-step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "Basic controls were included to validate the assay.",
        "judgment": "Yes",
        "reasoning": "The paper mentions that basic controls (normal/positive) were used in the assay."
      },
      {
        "step_name": "Sub-step 3b: Accepted/Validated Assay",
        "extracted_paper_info": "No specific validation was cited for this instance of the assay.",
        "judgment": "Do not use PS3/BS3",
        "reasoning": "The paper does not mention prior validation or references to a commercial kit."
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "Variant controls were used in the assay for this variant.",
        "judgment": "Yes",
        "reasoning": "The paper includes information about using variant controls to assess the impact of each mutation."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "Statistical analyses were used to estimate OddsPath for functional data.",
        "judgment": "Yes",
        "reasoning": "The paper mentions the calculation of OddsPath values."
      },
      {
        "step_name": "Sub-step 4a: Statistical Analyses",
        "extracted_paper_info": "Statistical tests and p-values were mentioned but not detailed in this context.",
        "judgment": "No statistical analysis details provided",
        "reasoning": "The paper does not provide specific statistical methods or p-values."
      },
      {
        "step_name": "Sub-step 4b: No OddsPath Calculation",
        "extracted_paper_info": "No OddsPath value was calculated in this study.",
        "judgment": "No OddsPath provided",
        "reasoning": "The paper does not report an OddsPath calculation."
      },
      {
        "step_name": "Sub-step 4c: Correlate OddsPath",
        "extracted_paper_info": "OddsPath values were calculated for each variant.",
        "judgment": "Yes, OddsPath was calculated for this variant.",
        "reasoning": "The paper provides OddsPath values."
      }
    ],
    "variant_controls": [
      {
        "variant_string_id": "LRRK2 G2019S",
        "status": "Pathogenic"
      }
    ],
    "evidence_summary": {
      "G2019S": "The variant G2019S was found to stimulate kinase activity in LRRK2, indicating its likely pathogenic role with supporting evidence."
    },
    "odds_path": {
      "G2019S": 3.5
    },
    "functional_evidence_strength": {
      "G2019S": "PS3_supporting"
    }
  }
}